IP Verse

Pharmaceutical Composition Having Desirable Bioavailability - EP2599475

The patent EP2599475 was granted to Alcon Research on Apr 26, 2017. The application was originally filed on Mar 13, 2009 under application number EP12193597A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2599475

ALCON RESEARCH
Application Number
EP12193597A
Filing Date
Mar 13, 2009
Status
Opposition Rejected
Sep 27, 2024
Grant Date
Apr 26, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFRED E TIEFENBACHERJan 26, 2018HAMM & WITTKOPPADMISSIBLE
GENERICS UK TRADING MYLANJan 26, 2018GILL JENNINGS & EVERYADMISSIBLE

Patent Citations (29) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONJP2003104870
DESCRIPTIONUS2002122831
DESCRIPTIONUS3931319
DESCRIPTIONUS4027020
DESCRIPTIONUS4407791
DESCRIPTIONUS4522806
DESCRIPTIONUS4525346
DESCRIPTIONUS4836986
DESCRIPTIONUS5037647
DESCRIPTIONUS5221664
DESCRIPTIONUS5300287
DESCRIPTIONUS5320843
DESCRIPTIONUS5741817
DESCRIPTIONUS5817277
DESCRIPTIONUS6017861
DESCRIPTIONUS6034043
DESCRIPTIONUS6319464
DESCRIPTIONUS6348190
DESCRIPTIONUS6482799
DESCRIPTIONUS6503497
DESCRIPTIONWO9109523
OPPOSITIONUS2002009507
OPPOSITIONWO0003736
SEARCHEP1547599
SEARCHUS2004082660
SEARCHUS6743439
SEARCHWO0003736
SEARCHWO9819680
SEARCHWO9841208

Non-Patent Literature (NPL) Citations (7) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- BAUDOUIN CHRISTOPHE ET AL, "In vitro studies of antiglaucomatous prostaglandin analogues: Travoprost with and without benzalkonium chloride and preserved latanoprost", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE - IOVS, ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, US, (20070901), vol. 48, no. 9, doi:10.1167/IOVS.07-0266, ISSN 0146-0404, pages 4123 - 4128, XP002607568
OPPOSITION- Department of Health and Human Services, "Travatan® Z", Pharmacology Review - Application number 21-994, (20060302), XP055456902
OPPOSITION- NEAL L. BURSTEIN, "Chapter 1 : Basic Science of Ocular Pharmacology", NEAL L. BURSTEIN, Jimmy D. Bartlett, Clinical Ocular Pharmacology, 2nd edition, Butterworth-Heinemann, (19890517), pages 3 - 10, XP055456908
OPPOSITION- Richard W. Yee, "The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review", Current Opinion In Ophthalmology, (20070000), vol. 18, pages 134 - 139, XP055456925
OPPOSITION- David A Ammar; Robert Ammar; Malik Noecker; Kahook, "Effects of Benzalkonium Chloride-Preserved, Polyquad-Preserved, and sofZia-Preserved Topical Glaucoma Medications on Human Ocular Eoithelial Cells", Advances in Therapy,, (20101100), vol. 27, no. 11, pages 837 - 845, XP055097387
OPPOSITION- LABBE et al., "Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study", JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS,, (20060800), vol. 22, no. 4, pages 267 - 278, XP055264197
OPPOSITION- Bernal Et Al, "Quantitative evaluation of the corneal epithelial barrier: effect of artificial tears and preservatives", Current Eye Research, (19910000), vol. 10, no. 7, pages 645 - 656, XP055265030

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents